Upcoming IPOs
All IPOs

Symbiotec Pharmalab IPO GMP

Listed

Pharmaceuticals · Listed on BSE , NSE · 24 Aug 2026 - 27 Aug 2026

Jagat JoshiJagat Joshi
November 6, 2026
Issue Size
1757.00 Cr
Price Band
₹938.00 - ₹988.00
Lot Size
15 Shares
Min Investment
₹14,820
GMP
₹185
Subscription
52.89x
₹92,952.26 Cr
IPO Timeline
IPO OpensDONE
24 Aug 2026
IPO ClosesDONE
27 Aug 2026
Basis of AllotmentDONE
28 Aug 2026
RefundsDONE
31 Aug 2026
Demat CreditDONE
31 Aug 2026
ListingDONE
01 Sept 2026

About Symbiotec Pharmalab IPO

Symbiotec Pharmalab IPO open date is August 24, 2026 and the IPO will close on August 27, 2026. Symbiotec Pharmalab IPO is a Book built Issue. The company to raise around ₹1757 crores via IPO that comprises fresh issue of ₹150 crores and offer for sale up to 1,62,65,181 equity shares with face value of ₹2 each.

Symbiotec Pharmalab IPO price band is ₹938 to ₹988 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Symbiotec Pharmalab IPO to list on BSE, NSE on September 1, 2026. The allotment of Symbiotec Pharmalab IPO date is August 28, 2026.

The company reported revenue of ₹872.26 crores in 2026 against ₹755.98 crores in 2025. The company reported profit of ₹109.90 crores in 2026 against profit of ₹96.79 crores in 2025. As per the financials, the IPO investors should apply the IPO for a long term.

Advertisement
Back to IPO Details

Day-wise GMP Trend

Date & TimeGMP (₹)Est. Listing PriceEst. Gain (%)Est. Profit / Lot (₹)
01-Sep-2026 12:00 PM+₹185₹1173+18.72%₹2,775
31-Aug-2026 12:00 PM+₹205₹1193+20.75%₹3,075
30-Aug-2026 12:00 PM+₹260₹1248+26.32%₹3,900
28-Aug-2026 12:00 PM+₹270₹1258+27.33%₹4,050
27-Aug-2026 12:00 PM+₹275₹1263+27.83%₹4,125
26-Aug-2026 12:00 PM+₹333₹1321+33.70%₹4,995
25-Aug-2026 12:00 PM+₹340₹1328+34.41%₹5,100
24-Aug-2026 12:00 PM+₹388₹1376+39.27%₹5,820
22-Aug-2026 12:00 PM+₹380₹1368+38.46%₹5,700
21-Aug-2026 12:00 PM+₹320₹1308+32.39%₹4,800
20-Aug-2026 12:00 PM+₹260₹1248+26.32%₹3,900

Symbiotec Pharmalab IPO GMP is ₹185 updated as of 01-Sep-2026 12:00 PM. The estimated listing gain for Symbiotec Pharmalab is 18.72% with an estimated profit of ₹2,775 per applied lot. Based on the latest GMP, the IPO may list at ₹1173.

Symbiotec Pharmalab GMP touched a high of ₹388 on 24 Aug 2026, while the lowest GMP of ₹185 was recorded on 01 Sept 2026.

The GMP is available with historical trend, estimated listing price and day-wise grey market movement. The IPO GMP is an unofficial indicator that reflects investor-market sentiment, and demand for an IPO in unofficial market before listing. However, it may fluctuate based on investor demand, market conditions and overall sentiment.

Disclaimer:

The IPO GMP and estimated listing price mentioned on this page are provided for informational and educational purposes only. The grey market is unofficial and unregulated and can change without notice.

We do not buy or sell IPO applications in the grey market. Investors should not subscribe to an IPO based on GMP. Please do your own research and consider the company’s fundamentals, financial information, valuation, and risk factors before investing in an IPO.

Stock market investments are subject to market risks. Please read all offer-related documents carefully before investing.

Advertisement

Symbiotec Pharmalab IPO Lot Size & Estimated Profit

ApplicationLotsSharesEst. Profits (₹)
Individual investors (Retail) (Min)115+₹2,775
Individual investors (Retail) (Max)13195+₹36,075
S-HNI (Min)14210+₹38,850
S-HNI (Max)671,005+₹1,85,925
B-HNI (Min)681,020+₹1,88,700

Grey Market Premium Chart

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by